5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 27.14▲ | 27.07▲ | 27.07▲ | 26.65▲ | 32.75▼ |
MA10 | 27.07▲ | 27.07▲ | 27.23▼ | 27.70▼ | 31.60▼ |
MA20 | 27.05▲ | 27.28▼ | 27.15▲ | 32.50▼ | 29.20▼ |
MA50 | 27.07▲ | 26.78▲ | 26.29▲ | 31.15▼ | 38.72▼ |
MA100 | 27.24▼ | 26.26▲ | 31.38▼ | 28.86▼ | 41.72▼ |
MA200 | 27.17▼ | 31.86▼ | 32.68▼ | 33.06▼ | 24.98▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.023▲ | -0.064▼ | -0.014▼ | -0.978▼ | 0.853▲ |
RSI | 57.812▲ | 51.226▲ | 52.137▲ | 40.418▼ | 43.726▼ |
STOCH | 93.875▲ | 29.180 | 22.455 | 27.429 | 65.497 |
WILL %R | -9.091▲ | -75.194▼ | -57.738 | -79.285▼ | -79.285▼ |
CCI | 124.342▲ | -32.529 | -43.497 | -38.490 | -71.268 |
BBANDS | $VKTX Bollinger Bands Expanding | Set Alert |
Wednesday, August 27, 2025 05:23 AM
A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway success of Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy. These injectable GLP-1 ...
|
Tuesday, August 26, 2025 04:15 AM
Eli Lilly (NYSE:LLY) announced on Tuesday that its oral weight loss therapy, orforglipron, reached the main goals in a second Phase 3 trial, allowing the company to move forward with global regulatory ...
|
Tuesday, August 26, 2025 03:15 AM
Viking's 40% crash over fixable dosing issues ignores its best-in-class 12.2% oral weight loss and Phase 3 momentum.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
29/08/25 | 27.715 | 28.12 | 26.83 | 27.15 | 2,954,527 |
28/08/25 | 26.87 | 28.05 | 26.70 | 27.58 | 5,809,302 |
27/08/25 | 26.00 | 27.50 | 25.8601 | 26.62 | 7,493,322 |
26/08/25 | 25.50 | 26.12 | 24.77 | 26.04 | 7,298,564 |
25/08/25 | 25.83 | 26.47 | 25.07 | 25.85 | 8,603,767 |
22/08/25 | 25.38 | 26.65 | 24.96 | 26.00 | 10,593,655 |
21/08/25 | 25.665 | 25.75 | 24.5701 | 25.66 | 9,018,420 |
20/08/25 | 24.605 | 26.74 | 24.53 | 25.69 | 23,763,211 |
19/08/25 | 26.00 | 26.2499 | 23.21 | 24.36 | 64,601,040 |
18/08/25 | 40.38 | 42.23 | 40.35 | 42.09 | 5,098,210 |
|
|
||||
|
|
||||
|
|